These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29349771)

  • 1. CYP2D6 Protein Level Is the Major Contributor to Interindividual Variability in CYP2D6-Mediated Drug Metabolism in Healthy Human Liver Tissue.
    Ning M; Duarte JD; Rubin LH; Jeong H
    Clin Pharmacol Ther; 2018 Nov; 104(5):974-982. PubMed ID: 29349771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohort.
    Dodgen TM; Labuschagne CJ; van Schalkwyk A; Steffens FE; Gaedigk A; Cromarty AD; Alessandrini M; Pepper MS
    Pharmacogenomics J; 2016 Nov; 16(6):566-572. PubMed ID: 26503815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2D6 Genotype Phenotype Discordance Due to Drug-Drug Interaction.
    Monte AA; West K; McDaniel KT; Flaten HK; Saben J; Shelton S; Abdelmawla F; Bushman LR; Williamson K; Abbott D; Anderson PL
    Clin Pharmacol Ther; 2018 Nov; 104(5):933-939. PubMed ID: 29882961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited effects of frequent CYP2D6*36-*10 tandem duplication allele on in vivo dextromethorphan metabolism in a Japanese population.
    Kiyotani K; Shimizu M; Kumai T; Kamataki T; Kobayashi S; Yamazaki H
    Eur J Clin Pharmacol; 2010 Oct; 66(10):1065-8. PubMed ID: 20700584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of Cytochrome P450 2D6 mRNA Levels in Healthy Human Liver Tissue.
    Ning M; Duarte JD; Stevison F; Isoherranen N; Rubin LH; Jeong H
    Clin Transl Sci; 2019 Jul; 12(4):416-423. PubMed ID: 30821899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of CYP2D6 deletion, multiplication, -1584C-->G, 31G-->A and 2988G-->a gene polymorphisms on dextromethorphan metabolism among Mexican tepehuanos and mestizos.
    Sosa-Macías M; Dorado P; Alanis-Bañuelos RE; Llerena A; Lares-Asseff I
    Pharmacology; 2010; 86(1):30-6. PubMed ID: 20588073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrogation of CYP2D6 Structural Variant Alleles Improves the Correlation Between CYP2D6 Genotype and CYP2D6-Mediated Metabolic Activity.
    Dalton R; Lee SB; Claw KG; Prasad B; Phillips BR; Shen DD; Wong LH; Fade M; McDonald MG; Dunham MJ; Fowler DM; Rettie AE; Schuetz E; Thornton TA; Nickerson DA; Gaedigk A; Thummel KE; Woodahl EL
    Clin Transl Sci; 2020 Jan; 13(1):147-156. PubMed ID: 31536170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel functional variants and extensive evaluation of CYP2D6 genetic polymorphisms in Koreans.
    Lee SJ; Lee SS; Jung HJ; Kim HS; Park SJ; Yeo CW; Shin JG
    Drug Metab Dispos; 2009 Jul; 37(7):1464-70. PubMed ID: 19364831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.
    Sachse C; Brockmöller J; Bauer S; Roots I
    Am J Hum Genet; 1997 Feb; 60(2):284-95. PubMed ID: 9012401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of interindividual variability and extent of CYP2D6 and CYP1A2 inhibition by paroxetine and fluvoxamine in vivo.
    Ozdemir V; Naranjo CA; Shulman RW; Herrmann N; Sellers EM; Reed K; Kalow W
    J Clin Psychopharmacol; 1998 Jun; 18(3):198-207. PubMed ID: 9617978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.
    Zhou SF
    Clin Pharmacokinet; 2009; 48(11):689-723. PubMed ID: 19817501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of CYP2D6 polymorphisms on dextromethorphan metabolism in Mexican Americans.
    Casner PR
    J Clin Pharmacol; 2005 Nov; 45(11):1230-5. PubMed ID: 16239355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter-individual variability of in vivo CYP2D6 activity in different genotypes.
    Chiba K; Kato M; Ito T; Suwa T; Sugiyama Y
    Drug Metab Pharmacokinet; 2012; 27(4):405-13. PubMed ID: 22277677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of CYP2D6.31 variant: homology modeling suggests possible disruption of redox partner interaction by Arg440His substitution.
    Allorge D; Bréant D; Harlow J; Chowdry J; Lo-Guidice JM; Chevalier D; Cauffiez C; Lhermitte M; Blaney FE; Tucker GT; Broly F; Ellis SW
    Proteins; 2005 May; 59(2):339-46. PubMed ID: 15726636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-sensitive reversible and time-dependent CYP2D6 inhibition in human liver microsomes.
    Storelli F; Desmeules J; Daali Y
    Basic Clin Pharmacol Toxicol; 2019 Feb; 124(2):170-180. PubMed ID: 30192434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoxifen levels and its association with CYP2D6 genotype and phenotype: evaluation of a southern Brazilian population under tamoxifen pharmacotherapy.
    Antunes MV; Linden R; Santos TV; Wallemacq P; Haufroid V; Classen JF; Andreolla H; Costa N; Fontanive TO; Rosa DD
    Ther Drug Monit; 2012 Aug; 34(4):422-31. PubMed ID: 22777153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinated intrahepatic and extrahepatic regulation of cytochrome p4502D6 in healthy subjects and in patients after liver transplantation.
    Carcillo JA; Adedoyin A; Burckart GJ; Frye RF; Venkataramanan R; Knoll C; Thummel K; Roskos L; Wilson JW; Sereika S; Romkes M; Bebia Z; Branch RA
    Clin Pharmacol Ther; 2003 May; 73(5):456-67. PubMed ID: 12732845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17.
    Shen H; He MM; Liu H; Wrighton SA; Wang L; Guo B; Li C
    Drug Metab Dispos; 2007 Aug; 35(8):1292-300. PubMed ID: 17470523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and Caucasians.
    Droll K; Bruce-Mensah K; Otton SV; Gaedigk A; Sellers EM; Tyndale RF
    Pharmacogenetics; 1998 Aug; 8(4):325-33. PubMed ID: 9731719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug metabolism of CYP3A4, CYP2C9 and CYP2D6 substrates in pigs and humans.
    Thörn HA; Lundahl A; Schrickx JA; Dickinson PA; Lennernäs H
    Eur J Pharm Sci; 2011 Jun; 43(3):89-98. PubMed ID: 21447389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.